## ðŸ‘¨â€ðŸ”¬ Structural Bioinformatics & Molecular Modeling Portfolio

> This repository serves as a **unified professional portfolio** consolidating **19 distinct projects** that demonstrate advanced skills in Structural Biology, Molecular Modeling, and Systems Analysis. The collection showcases my ability to apply computational techniques to complex protein function, drug design, and translational data interpretation.

### âœ… Demonstrated Professional and Technical Proficiency

| Competency Area | Description Emphasizing Human Effort | Primary Tools & Techniques Used |
| :---: | :--- | :--- |
| **I. Structural Biology & Modeling** | **I personally executed** detailed workflows for Homology Modeling (using SWISS-MODEL), analyzed PDB structures, and applied principles of molecular dynamics and refinement. | **SWISS-MODEL**, PDB Analysis, **Homology Modeling**, Protein Structure Refinement. |
| **II. Computational Drug Design (CADD)** | **I focused on applying** **Structure-Based Drug Design (SBDD)** principles through protein-ligand docking against relevant targets, including SARS-CoV-2 and inflammation markers. | **Molecular Docking**, Ligand-Protein Interaction Analysis, Target Validation. |
| **III. Systems & Evolutionary Analysis** | **I mastered the interpretation** of high-throughput data, mapping biological pathways (KEGG, Reactome), building PPI networks, and performing robust evolutionary (phylogenetic) inference. | **KEGG, REACTOME**, **STRING Database**, CLUSTAL OMEGA, MUSCLE (EMBL-EBI). |

---

### ðŸ“‚ Detailed Project Log: 19 Repositories (Structured List)

#### Category I: Systems Biology, Databases & Multi-Omic Analysis (4 Projects)

This section highlights high-level biological data interpretation and systems-level thinking.

* **1. [**Large-scale-Multi-omic-Analysis-of-COVID-19-Severity**](https://github.com/DrNagendra619/Large-scale-Multi-omic-Analysis-of-COVID-19-Severity)**
    * **Goal:** Integrate and analyze diverse genomic and proteomic data sets related to COVID-19 severity.
    * **Outcome:** Gained experience in data fusion and translational bioinformatics.

* **2. [**String-database-Protein-Protein-Interactions-Network**](https://github.com/DrNagendra619/String-database-Protein-Protein-Interactions-Network)**
    * **Goal:** Map functional relationships between proteins.
    * **Outcome:** Successfully constructed and interpreted a **Protein-Protein Interaction (PPI) Network** using the STRING database.

* **3. [**KEGG-DATABASE-PATHWAYS**](https://github.com/DrNagendra619/KEGG-DATABASE-PATHWAYS)**
    * **Goal:** Map biological molecules to known metabolic and signaling routes.
    * **Outcome:** Performed pathway enrichment analysis using the **KEGG Database**.

* **4. [**REACTOME-DATABASE-PATHYWAYS**](https://github.com/DrNagendra619/REACTOME-DATABASE-PATHYWAYS)**
    * **Goal:** Analyze molecular events in greater mechanistic detail.
    * **Outcome:** Performed pathway analysis using the **REACTOME Database** for reaction-level context.

#### Category II: Evolutionary & Sequence Modeling (4 Projects)

This category establishes proficiency in sequence comparison and phylogenetic methods using industry-standard tools.

* **5. [**PHYLOGENETIC-TREE-of-INSULIN-MUSCLE-TOOL**](https://github.com/DrNagendra619/CONSTRUCTING-A-PHYLOGENETIC-TREE-of-INSULIN-USING-EMBL-EBI-MUSCLE-TOOL)**
    * **Focus:** Evolutionary Inference. **Goal:** Infer the evolutionary history of Insulin sequences.
    * **Outcome:** Successfully used the **EMBL-EBI MUSCLE** tool for multiple sequence alignment and phylogenetic tree construction.

* **6. [**PHYLOGENETIC-TREE-of-INSULIN-CLUSTAL-OMEGA-TOOL**](https://github.com/DrNagendra619/CONSTRUCTING-A-PHYLOGENETIC-TREE-of-INSULIN-CLUSTAL-OMEGA-TOOL)**
    * **Focus:** Comparative Analysis. **Goal:** Validate evolutionary inference using a different algorithm.
    * **Outcome:** Used the **EMBL-EBI CLUSTAL OMEGA** tool for comparative phylogenetic analysis of Insulin.

* **7. [**PHYLOGENETIC-TREE-of-Hemoglobin-MUSLCE-TOOL**](https://github.com/DrNagendra619/CONSTRUCTING-A-PHYLOGENETIC-TREE-of-Hemoglobin-EMBL-EBI-MUSLCE-TOOL)**
    * **Focus:** Evolutionary Inference. **Goal:** Infer the evolutionary history of Hemoglobin sequences.
    * **Outcome:** Applied the **MUSCLE** tool for alignment and tree generation.

* **8. [**PHYLOGENETIC-TREE-of-Hemoglobin-CLUSTAL-OMEGA-TOOL**](https://github.com/DrNagendra619/CONSTRUCTING-A-PHYLOGENETIC-TREE-of-Hemoglobin-EMBL-EBI-CLUSTAL-OMEGA-TOOL)**
    * **Focus:** Comparative Analysis. **Goal:** Validate evolutionary inference for Hemoglobin.
    * **Outcome:** Applied the **CLUSTAL OMEGA** tool for alignment and tree generation.

#### Category III: Structural Biology, Homology Modeling & Drug Design (11 Projects)

This section showcases the progression from structure analysis to building new models and applying them in drug discovery.

* **9. [**Protein-2-Structure-analysis-1AO3...**](https://github.com/DrNagendra619/Protein-2-Structure-analysis-1AO3-A3-DOMAIN-OF-VON-WILLEBRAND-FACTOR-)**
    * **Focus:** Structural Analysis (PDB). **Goal:** Analyze an existing PDB file for functional regions.
    * **Outcome:** Performed structural analysis and interpretation of the **Von Willebrand Factor** A3 Domain (1AO3).

* **10. [**Protein-2-Structure-analysis-1KTH...**](https://github.com/DrNagendra619/Protein-2-Structure-analysis-1KTH-Anisotropic-Refinement-Of-Kunitz-Type-Domain-C5-at-0.95-Angstrom)**
    * **Focus:** Structural Analysis (PDB Refinement). **Goal:** Analyze high-resolution PDB data.
    * **Outcome:** Interpreted structural features from the **Kunitz-Type Domain C5** at high resolution (1KTH).

* **11. [**Protein-2-Structure-analysis-6KA9...**](https://github.com/DrNagendra619/Protein-2-Structure-analysis-6KA9-Crosslinked-alpha-Fe-CO--beta-Ni-human-hemoglobin-A)**
    * **Focus:** Structural Analysis (PDB). **Goal:** Analyze structural modifications in proteins.
    * **Outcome:** Interpreted PDB data for **Crosslinked Human Hemoglobin** (6KA9).

* **12. [**PROTEIN-STRUCTURE-MODELLING-SWISS-MODELLING--2DN1...**](https://github.com/DrNagendra619/PROTEIN-STRUCTURE-MODELLING-SWISS-MODELLING--2DN1-Human-Hemoglobin)**
    * **Focus:** Homology Modeling. **Goal:** Predict 3D structure from a sequence.
    * **Outcome:** Successfully modeled **Human Hemoglobin** using **SWISS-MODEL**.

* **13. [**PROTEIN-STRUCTURE-MODELLING-SWISS-MODELLING-2QAC...**](https://github.com/DrNagendra619/PROTEIN-STRUCTURE-MODELLING-SWISS-MODELLING-2QAC-closed-MTIP-MyosinA-tail-complex)**
    * **Focus:** Homology Modeling. **Goal:** Model a complex protein structure.
    * **Outcome:** Successfully modeled the **MTIP-MyosinA-tail complex** (2QAC) using SWISS-MODEL.

* **14. [**PROTEIN-STRUCTURE-MODELLING-SWISS-MODELLING-7LYH...**](https://github.com/DrNagendra619/PROTEIN-STRUCTURE-MODELLING-SWISS-MODELLING-7LYH-Crystal-structure-of-the-SARS-CoV-2)**
    * **Focus:** Homology Modeling. **Goal:** Model a contemporary viral target.
    * **Outcome:** Successfully modeled a **SARS-CoV-2 protein** (7LYH) using SWISS-MODEL.

* **15. [**PROTEIN-STRUCTURE-SWISS-MODELLING--7BF4...**](https://github.com/DrNagendra619/PROTEIN-STRUCTURE-SWISS-MODELLING--7BF4-Crystal-structure-of-SARS-CoV-2)**
    * **Focus:** Homology Modeling. **Goal:** Model a second viral target for comparison.
    * **Outcome:** Successfully modeled a second **SARS-CoV-2 protein** (7BF4) using SWISS-MODEL.

* **16. [**PROTEIN-STRUCTURE-SWISS-MODELLING-2ZNS...**](https://github.com/DrNagendra619/PROTEIN-STRUCTURE-SWISS-MODELLING-2ZNS-Structure-of-ligand-binding-core-of-human-glutamate-receptor)**
    * **Focus:** Homology Modeling. **Goal:** Model a neurological target.
    * **Outcome:** Successfully modeled the structure of the human **glutamate receptor** (2ZNS) using SWISS-MODEL.

* **17. [**PROTEIN-LIGAND-DOCKING-6Y3C-Human-COX-1...**](https://github.com/DrNagendra619/PROTEIN-LIGAND-DOCKING-6Y3C-Human-COX-1-Crystal-Structure-)**
    * **Focus:** Drug Design (SBDD). **Goal:** Simulate drug-target binding.
    * **Outcome:** Performed **Protein-Ligand Docking** against the **Human COX-1** enzyme (6Y3C).

* **18. [**PROTEIN-LIGAND-DOCKING-7L0D-SARS-CoV-2...**](https://github.com/DrNagendra619/PROTEIN-LIGAND-DOCKING-7L0D-SARS-CoV-2-Main-Protease-Mpro-in-Complex-with-ML188-)**
    * **Focus:** Drug Design (SBDD). **Goal:** Simulate binding for an urgent target.
    * **Outcome:** Performed **Protein-Ligand Docking** against the **SARS-CoV-2 Main Protease (Mpro)** (7L0D).

* **19. [**PROTEIN-LIGAND-DOCKING-8IFR-SARS-CoV-2...**](https://github.com/DrNagendra619/PROTEIN-LIGAND-DOCKING-8IFR-SARS-CoV-2-3CL-protease-3CLpro-in-complex-with-compound-3-)**
    * **Focus:** Drug Design (SBDD). **Goal:** Validate docking results against another key viral target.
    * **Outcome:** Performed **Protein-Ligand Docking** against the **SARS-CoV-2 3CL Protease** (8IFR).

---

### ðŸŽ“ Personal Statement and Future Direction

> This portfolio rigorously documents my commitment to **Structure-Based Drug Design (SBDD)** and advanced computational analysis. By mastering techniques from homology modeling to molecular docking and systems mapping, I have established a specialized skill set ready for immediate application in **Pharmaceutical Research and Industrial Bioinformatics** roles.
